Sound Financial Strategies Group LLC Buys 13,864 Shares of Kenvue Inc. (NYSE:KVUE)

Sound Financial Strategies Group LLC lifted its stake in Kenvue Inc. (NYSE:KVUE) by 50.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 41,382 shares of the company’s stock after purchasing an additional 13,864 shares during the period. Kenvue comprises about 0.7% of Sound Financial Strategies Group LLC’s investment portfolio, making the stock its 22nd largest position. Sound Financial Strategies Group LLC’s holdings in Kenvue were worth $884,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also recently made changes to their positions in the company. Grove Bank & Trust grew its holdings in shares of Kenvue by 438.4% in the fourth quarter. Grove Bank & Trust now owns 1,163 shares of the company’s stock worth $25,000 after purchasing an additional 947 shares during the last quarter. Geneos Wealth Management Inc. purchased a new stake in Kenvue in the fourth quarter worth about $29,000. SRS Capital Advisors Inc. lifted its stake in Kenvue by 67.4% in the fourth quarter. SRS Capital Advisors Inc. now owns 1,418 shares of the company’s stock worth $30,000 after acquiring an additional 571 shares during the period. Ashton Thomas Securities LLC purchased a new stake in Kenvue in the third quarter worth about $35,000. Finally, Fortitude Family Office LLC lifted its stake in Kenvue by 106.6% in the fourth quarter. Fortitude Family Office LLC now owns 1,506 shares of the company’s stock worth $32,000 after acquiring an additional 777 shares during the period. 97.64% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of analysts recently weighed in on KVUE shares. UBS Group lowered their price objective on shares of Kenvue from $23.00 to $21.00 and set a “neutral” rating for the company in a research note on Friday, February 7th. Barclays decreased their price target on shares of Kenvue from $23.00 to $21.00 and set an “equal weight” rating for the company in a research report on Friday, January 17th. Piper Sandler increased their price target on shares of Kenvue from $24.00 to $27.00 and gave the company an “overweight” rating in a research report on Monday, February 24th. Deutsche Bank Aktiengesellschaft lowered shares of Kenvue from a “buy” rating to a “hold” rating and decreased their price target for the company from $25.00 to $24.00 in a research report on Thursday, December 12th. Finally, Royal Bank of Canada restated a “sector perform” rating and set a $24.00 price objective on shares of Kenvue in a report on Monday, February 3rd. One equities research analyst has rated the stock with a sell rating, seven have assigned a hold rating and five have issued a buy rating to the stock. According to data from MarketBeat, Kenvue has an average rating of “Hold” and a consensus target price of $23.33.

Kenvue Price Performance

Shares of NYSE KVUE opened at $23.44 on Wednesday. The stock has a market capitalization of $44.79 billion, a price-to-earnings ratio of 44.22, a PEG ratio of 2.62 and a beta of 1.45. Kenvue Inc. has a 12 month low of $17.67 and a 12 month high of $24.46. The firm’s 50 day simple moving average is $21.54 and its 200-day simple moving average is $22.30. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.00 and a quick ratio of 0.69.

Kenvue (NYSE:KVUE) last announced its earnings results on Thursday, February 6th. The company reported $0.26 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.26. Kenvue had a return on equity of 20.97% and a net margin of 6.66%. Analysts expect that Kenvue Inc. will post 1.14 EPS for the current year.

Kenvue Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, February 26th. Stockholders of record on Wednesday, February 12th were given a dividend of $0.205 per share. The ex-dividend date of this dividend was Wednesday, February 12th. This represents a $0.82 dividend on an annualized basis and a dividend yield of 3.50%. Kenvue’s dividend payout ratio (DPR) is 154.72%.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.